Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  adenovirus encoding tyrosinase, MART-1/MAGE-A6-transduced autologous dendritic cell vaccine
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Vaccine Therapy With or Without Recombinant Interferon Alfa-2b in Treating Patients With Recurrent Stage III-IV Melanoma
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: 09-021, NCI-2013-00388, UPCI 09-021, NCT01622933
Start Over